MICROSOFT IS DEVELOPING A GLASSES-BASED BLOOD PRESSURE MONITOR
Microsoft is developing new blood pressure monitoring technology called Glabella, which comes equipped on a pair of glasses that passively collects physiological data on the wearer, according to a research paper recently released by the company. The paper was written by Christian Holz, Microsoft Research in Redmond; and Edward J.
FIRST MR THEATER IN U.S. OPENS AT PARRISH HEALTHCARE IN FLORIDA
Patients at the Parrish Healthcare Center in Titusville, Fla., are the first to have access to enhanced comfort during Magnetic Resonance (MR) exams thanks to the installation of the nation’s first Vantage Titan / Zen Edition 1.5T MR Theater from Canon Medical Systems USA Inc. The new MR theater projects peaceful, virtual reality
PREPARING A NEW GENERATION OF PHYSICIANS FOR A NEW KIND OF HEALTH CARE
By David Muhlestein, PhD, JD and Lia Winfield, PhD Dramatic changes in the demographics of our physician population are happening at the same time as our healthcare system is making equally dramatic changes in how it organizes and pays for care. This new generation of physicians is likely to be
STUDY SHOWS RESULTS CHANGING WHITE FAT INTO BROWN FAT FOR EASIER WEIGHT LOSS
Obesity results from excess white fat storage, making it difficult to treat because the effectiveness of diet, exercise, and systemic anti-obesity agents is limited, and in the latter case may cause serious side effects. As a result, researchers are investigating innovative strategies for localized delivery of fat burning compounds via
AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET
Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.). Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D. The Company intends to launch two versions
VENA CAVA FILTERS TO SEE DOUBLE-DIGIT CAGR ANNUAL GROWTH
The global inferior vena cava filters (IVCFs)market is expected to grow at a compounded annual growth rate (CAGR) of more than 11 percent during the period 2018-2022, according to a new 126-page market research study (SKU: IRTNTR21662) published early this year by Technavio. A free sample report or the full
INTACT VASCULAR OFFERS TOBA BTK DATA
Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, has praised the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue of Catheterization and Cardiovascular Intervention. This multi-center pilot study focused on collecting data supporting
OPTALYSE PE: BTG RESULTS REINFORCE SAFETY, EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE
BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to
BTG OPTALYSE PE TRIAL RESULTS REINFORCE SAFETY AND EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE
BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to